Last reviewed · How we verify

NCT04291586

Comparing the Impact of Virtual Reality and Paper and Pencil on Psychosocial Rehabilitation

Completed NA Last updated 6 January 2021
What this trial tests

NA trial testing Virtual reality in Psychiatric Disease in 29 participants. Completed in 31 March 2020.

Timeline
3 June 2019
Primary endpoint
7 February 2020
31 March 2020

Quick facts

Lead sponsorInstituto Irmãs Hospitaleiras Sagrado Coração de Jesus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment29
Start date3 June 2019
Primary completion7 February 2020
Estimated completion31 March 2020
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Irmãs Hospitaleiras Sagrado Coração de Jesus

Who can join

Eligibility, female only, with Psychiatric Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Virtual Reality allows the integration of cognitive rehabilitation in a more ecologically valid context. The purpose of this study is to determine whether this methodology has more impact on psychosocial rehabilitation than a paper and pencil personalized program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Psychiatric Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04291586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing